Febumed Sp. z o.o.
- Address
- Ul. Bobrowiecka 1, 00-728 Warsaw, Poland
Febumed Sp. z o.o. - Allergy and Immunotherapy Research Center
Febumed Sp. z o.o. is a specialized clinical research center focused on advancing treatments for allergic conditions through innovative immunotherapy approaches. The center demonstrates particular expertise in evaluating novel therapeutic interventions for respiratory allergic diseases, with emphasis on optimizing treatment protocols and dosing regimens for allergen immunotherapy products.
- Allergen-specific immunotherapy for seasonal allergies and grass pollen sensitization
- Treatment optimization for allergic rhinoconjunctivitis with or without concomitant asthma
- Rush immunotherapy protocols and therapeutic dose establishment
The research center specializes in conducting studies that evaluate the effectiveness of polymerized allergen extracts, particularly those targeting grass pollen allergies. Their clinical trial portfolio includes investigations into allergic rhinoconjunctivitis management, addressing both isolated rhinoconjunctivitis and cases complicated by asthma. Febumed's research contributes to improving the quality of life for patients suffering from seasonal allergies by determining optimal therapeutic approaches and treatment regimens.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Probelte Pharma S.L.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Probelte Pharma S.L.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Febumed Sp. z o.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Dose-finding study of polymerized grass pollen extract in patients with allergic rhinoconjunctivitis with or without asthma | Probelte Pharma S.L. | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Allergenic Extract Of Grass Pollen Mixture: Dactylis Glomerata, Festuca Pratensis, Lolium Perenne, Phleum Pratense And Poa Pratensis (1:1:1:1:1), Polymerised | 2 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.